BioSpace News Archive

AlloVir to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Molecular Templates, Inc. today reported financial results for the third quarter of 2021.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will participate in a fireside chat during the Jefferies London Healthcare Conference, taking place virtually November 18 – 19, 2021.

Biogen Inc. announced that it has set an industry record as the most frequently recognized biotechnology company on the Dow Jones Sustainability World Index, earning recognition for the ninth consecutive year, more than any other biotechnology company.

Cytokinetics, Incorporated announced that additional results from GALACTIC-HF, the Phase 3 clinical trial evaluating omecamtiv mecarbil in patients with heart failure with reduced ejection fraction, were presented by Dr. John Teerlink, M.D., Professor of Medicine, University of California San Francisco, Director of Heart Failure, San Francisco Veterans Affairs Medical Center and Executive Committee Chair, GALACTIC-HF, at the American Heart Association Scientific Sessions 2021.

Trevi Therapeutics, Inc. today announced that Dr. Bill Forbes , Chief Development Officer, will be presenting at the 5th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases taking place from November 16-18, 2021 in Boston, MA.

Palatin Technologies, Inc. today announced results for its first fiscal quarter ended September 30, 2021.

Arrowhead Pharmaceuticals Inc. today announced additional Phase 1/2 clinical data on ARO-APOC3

Frequency Therapeutics, Inc. today announced business updates and financial results for the third quarter ended September 30, 2021.

Nuvo Pharmaceuticals Inc. today announced its financial and operational results for the three and nine months ended September 30, 2021.